Who Owns BioMarin Pharmaceutical Stock?
NASDAQ: BMRNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 103.57%
- Institutions (% of float)
- 103.92%
- Held by insiders
- 0.34%
- Institutional holders
- 758
- Institutions 99.7%
- Insiders 0.3%
- Public and other 0.0%
Who owns BioMarin Pharmaceutical stock?
Institutional investors own about 103.6% of BioMarin Pharmaceutical's shares, spread across 758 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.34% of BMRN.
The largest institutional holders are Blackrock Inc. (10.56%), Dodge & Cox Inc. (7.67%) and Primecap Management Company (7.33%). Together, the top 10 institutions control 52.8% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their BMRN positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BMRN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 20.45M | 10.56% | +3.2% |
| Dodge & Cox Inc. | 14.84M | 7.67% | +1.9% |
| Primecap Management Company | 14.19M | 7.33% | -0.0% |
| Vanguard Capital Management LLC | 8.74M | 4.52% | +1.2% |
| Vanguard Portfolio Management LLC | 8.65M | 4.47% | +4.2% |
| NORGES BANK | 8.21M | 4.24% | +9.0% |
| State Street Corporation | 7.80M | 4.03% | +6.9% |
| Viking Global Investors, L.P. | 7.62M | 3.93% | +7.8% |
| Vestal Point Capital, LP | 6.03M | 3.11% | +68.5% |
| AQR Capital Management, LLC | 5.70M | 2.94% | -25.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BMRN
| Fund | Shares | % Held |
|---|---|---|
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 9.77M | 5.05% |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 6.77M | 3.50% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 6.14M | 3.17% |
| VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund | 5.17M | 2.67% |
| VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund | 4.97M | 2.57% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 4.43M | 2.29% |
| Fidelity Contrafund | 2.84M | 1.47% |
| Capital World Growth & Income Fund | 2.58M | 1.33% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 2.55M | 1.32% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.22M | 1.15% |
Frequently asked questions
Who is the largest shareholder of BioMarin Pharmaceutical?
Blackrock Inc. is the largest institutional shareholder of BMRN, owning 10.56% of shares outstanding (20.45M shares) as of its latest 13F filing.
What percentage of BioMarin Pharmaceutical is owned by institutions?
Institutions own about 103.6% of BMRN shares and 103.9% of the public float.
How much of BioMarin Pharmaceutical do insiders own?
Insiders, such as officers and directors, own about 0.34% of BMRN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.